Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Variance in spatial and heterogeneity components, and proportion of the variance in mortality relative risk explained by the spatial structure of the models

From: Time trends in municipal distribution patterns of cancer mortality in Spain

  Men Women
Cancer site 1989-93 1994-98 1999-2003 2004-2008 1989-93 1994-98 1999-2003 2004-2008
Stomach
 Spatial 0.083 0.067 0.059 0.053 0.091 0.081 0.063 0.063
 Heterog 0.001 0.003 0.009 0.013 0.003 0.007 0.001 0.001
 sfv 0.99 0.95 0.86 0.81 0.97 0.92 0.98 0.98
Colorectal
 Spatial 0.040 0.036 0.033 0.017 0.026 0.021 0.011 0.011
 Heterog 0.022 0.012 0.020 0.017 0.003 0.009 0.012 0.001
 sfv 0.64 0.76 0.62 0.50 0.88 0.70 0.48 0.91
Lung
 Spatial 0.099 0.099 0.076 0.063 0.027 0.038 0.037 0.054
 Heterog 0.004 0.002 0.001 0.001 0.003 0.005 0.013 0.015
 sfv 0.97 0.98 0.98 0.98 0.90 0.89 0.74 0.79
Breast
 Spatial      0.039 0.028 0.017 0.020
 Heterog      0.013 0.008 0.007 0.001
 sfv      0.75 0.76 0.70 0.96
Prostate
 Spatial 0.014 0.013 0.014 0.007     
 Heterog 0.017 0.012 0.011 0.011     
 sfv 0.46 0.52 0.56 0.39     
Bladder
 Spatial 0.067 0.054 0.043 0.045 0.014 0.004 0.001 0.025
 Heterog 0.020 0.001 0.013 0.023 0.002 0.032 0.002 0.002
 sfv 0.77 0.98 0.77 0.66 0.88 0.12 0.30 0.93
  1. Spatial: spatially structured component variance.
  2. Heterog: unstructured component variance.
  3. Spatial fractional variance (sfv): var.RRspatial/(var.RRspatial + var.RRhet).